NCT00174538View on ClinicalTrials.gov

Codeine in Sickle Cell Disease

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

December 31, 2005

Conditions

Sickle Cell Disease

Interventions

DRUG

Codeine (30 mg)

Trial Locations (1)

60612

University of Illinois Medical Center, Chicago

All Listed Sponsors

lead

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

NCT00174538 - Codeine in Sickle Cell Disease | Biotech Hunter | Biotech Hunter